Covid-19 has initiated unprecedented demand as some of our customers race to develop vaccines and treatments, as well as continue the production of non-Covid-19 lifesaving and enhancing drugs.
In early 2020, at the outset of the pandemic, our business established three key principles which would support our ability to be agile as we based our decisions and prioritization off of the below critical areas:
- Employee Safety: ensure the safety and well-being of our employees and their families
- Public Health: play a positive role in supporting public health
- Business Continuity: sustain our business well beyond the crisis